drug
LEFLUNOMIDE
Marketedupdated 3mo agoby Abhai Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2indications
investigational
Rheumatoid Arthritis
all catalysts(8)
approval · 8
Sep 13, 2005
approval
LEFLUNOMIDE — FDA approval
LEFLUNOMIDE
→
Mar 2, 2006
approval
LEFLUNOMIDE — FDA approval
LEFLUNOMIDE
→
Oct 29, 2008
approval
LEFLUNOMIDE — FDA approval
LEFLUNOMIDE
→
Aug 29, 2011
approval
LEFLUNOMIDE — FDA approval
LEFLUNOMIDE
→
Aug 30, 2011
approval
LEFLUNOMIDE — FDA approval
LEFLUNOMIDE
→
Feb 15, 2016
approval
LEFLUNOMIDE — FDA approval
LEFLUNOMIDE
→
Apr 18, 2017
approval
LEFLUNOMIDE — FDA approval
LEFLUNOMIDE
→
Oct 24, 2025
approval
LEFLUNOMIDE — FDA approval
LEFLUNOMIDE
→
Trials studying LEFLUNOMIDE
- —A Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA® (Leflunomide) in Saudi Arabia
- phase1Leflunomide 20 mg Tablets Under Fasting Conditions
- phase1Leflunomide 20 mg Tablets, Non-Fasting
- phase4IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 47m ago
Found something off?
comments(0)
5-min edit window · permanent after that